Co-Diagnostics, Inc. (CODX)
4.755
-0.12
(-2.56%)
USD |
NASDAQ |
Jun 11, 09:50
Co-Diagnostics Enterprise Value : 11.38M for June 10, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 10, 2026 | 11.38M |
| June 09, 2026 | 10.01M |
| June 08, 2026 | 11.99M |
| June 05, 2026 | 14.08M |
| June 04, 2026 | 14.55M |
| June 03, 2026 | 12.42M |
| June 02, 2026 | 16.21M |
| June 01, 2026 | 16.13M |
| May 29, 2026 | 24.53M |
| May 28, 2026 | 34.11M |
| May 27, 2026 | 20.10M |
| May 26, 2026 | 26.62M |
| May 22, 2026 | 12.06M |
| May 21, 2026 | 7.165M |
| May 20, 2026 | 2.409M |
| May 19, 2026 | 0.8963M |
| May 18, 2026 | -1.265M |
| May 15, 2026 | -1.571M |
| May 14, 2026 | -0.3285M |
| May 13, 2026 | -0.4366M |
| May 12, 2026 | -0.0043M |
| May 11, 2026 | 0.6442M |
| May 08, 2026 | 2.914M |
| May 07, 2026 | 0.7522M |
| May 06, 2026 | -0.2925M |
| Date | Value |
|---|---|
| May 05, 2026 | -0.4726M |
| May 04, 2026 | -0.5447M |
| May 01, 2026 | -0.6167M |
| April 30, 2026 | -0.6167M |
| April 29, 2026 | -0.6888M |
| April 28, 2026 | -0.3285M |
| April 27, 2026 | -0.2565M |
| April 24, 2026 | -0.1844M |
| April 23, 2026 | -0.0403M |
| April 22, 2026 | -0.1124M |
| April 21, 2026 | -0.2925M |
| April 20, 2026 | -0.1844M |
| April 17, 2026 | -0.5807M |
| April 16, 2026 | -0.941M |
| April 15, 2026 | -1.085M |
| April 14, 2026 | -1.229M |
| April 13, 2026 | -0.977M |
| April 10, 2026 | -1.265M |
| April 09, 2026 | -1.013M |
| April 08, 2026 | -1.193M |
| April 07, 2026 | -1.085M |
| April 06, 2026 | -0.6708M |
| April 02, 2026 | -0.6528M |
| April 01, 2026 | -0.3646M |
| March 31, 2026 | 0.5001M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Fractyl Health, Inc. | 113.75M |
| Spectral AI, Inc. | 56.52M |
| Sangamo Therapeutics, Inc. | 53.47M |
| INmune Bio, Inc. | 12.32M |
| Arrowhead Pharmaceuticals, Inc. | 9.517B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -9.14M |
| Revenue (Quarterly) | 0.146M |
| Total Expenses (Quarterly) | 9.286M |
| EPS Diluted (Quarterly) | -4.056 |
| Gross Profit Margin (Quarterly) | -207.7% |
| Profit Margin (Quarterly) | -6.26K% |
| Earnings Yield | -589.1% |
| Normalized Earnings Yield | -456.39 |